National Institute on Deafness and Other Communication Disorders; Notice of Closed Meeting, 84166 [2024-24199]
Download as PDF
<![CDATA[
84166
Federal Register / Vol. 89, No. 203 / Monday, October 21, 2024 / Notices
Dated: October 16, 2024.
Bruce A. George,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–24239 Filed 10–18–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Office of the Director, National
Institutes of Health; Notice of Meeting
lotter on DSK11XQN23PROD with NOTICES1
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Advisory Committee on
Research on Women’s Health.
The meeting will be open to the
public as a virtual meeting. Individuals
who plan to view the virtual meeting
and need special assistance or other
reasonable accommodations to view the
meeting, should notify the Contact
Person listed below in advance of the
meeting. The meeting will be videocast
and can be accessed from the NIH
Videocasting and Podcasting website
(https://videocast.nih.gov/).
Name of Committee: Advisory Committee
on Research on Women’s Health.
Date: December 9, 2024.
Time: 1:00 p.m. to 3:00 p.m.
Agenda: Briefing on the National
Academies of Science, Engineering, and
Medicine’s (NASEM) Assessment of NIH
Research on Women’s Health.
Place: National Institutes of Health, 9000
Rockville Pike, Building 31, Bethesda, MD
20892 (In-Person and Virtual Meeting).
Contact Person: Vivian Ota Wang, Ph.D.,
FACMG, CGC, Deputy Director, Office on
Research for Women’s Health, Division of
Program Coordination, Planning and
Strategic Initiatives, National Institutes of
Health, 6707 Democracy Blvd., Bethesda, MD
20892, 240–550–9892, otawangv@nih.gov.
Any member of the public interested in
presenting oral comments to the committee
may notify the Contact Person listed on this
notice at least 10 days in advance of the
meetings. Interested individuals and
representatives of organizations may submit
a letter of intent, a brief description of the
organization represented, and a short
description of the oral presentation. Only one
representative of an organization may be
allowed to present oral comments and if
accepted by the committee, presentations
may be limited to five minutes. Both printed
and electronic copies are requested for the
record. In addition, any interested person
may file written comments with the
committee by forwarding their statement to
the Contact Person listed on this notice. The
statement should include the name, address,
telephone number and when applicable, the
business or professional affiliation of the
interested person.
VerDate Sep<11>2014
16:27 Oct 18, 2024
Jkt 265001
Information is also available on the
Institute’s/Center’s home page: https://
orwh.od.nih.gov/, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.14, Intramural Research
Training Award; 93.22, Clinical Research
Loan Repayment Program for Individuals
from Disadvantaged Backgrounds; 93.232,
Loan Repayment Program for Research
Generally; 93.39, Academic Research
Enhancement Award; 93.936, NIH Acquired
Immunodeficiency Syndrome Research Loan
Repayment Program; 93.187, Undergraduate
Scholarship Program for Individuals from
Disadvantaged Backgrounds, National
Institutes of Health, HHS)
(Catalogue of Federal Domestic Assistance
Program Nos. 93.173, Biological Research
Related to Deafness and Communicative
Disorders, National Institutes of Health, HHS)
Dated: October 15, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory
Committee Policy.
Final Scientific Integrity Policy of the
National Institutes of Health
[FR Doc. 2024–24238 Filed 10–18–24; 8:45 am]
ACTION:
BILLING CODE 4140–01–P
Dated: October 15, 2024.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–24199 Filed 10–18–24; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
AGENCY:
National Institutes of Health,
HHS.
Notice of final policy.
The National Institutes of
Health (NIH) is issuing this Final NIH
Scientific Integrity Policy to promote a
continuing culture of scientific integrity
at NIH. This Policy codifies NIH’s longstanding expectations to preserve
scientific integrity throughout all NIH
activities, establishes key roles and
responsibilities for those who will lead
the agency’s scientific integrity program,
and, as appropriate, establishes relevant
reporting and evaluation mechanisms.
DATES: This Final Policy is effective on
December 30, 2024.
FOR FURTHER INFORMATION CONTACT:
Jessica Tucker, Ph.D., Acting Deputy
Director, Office of Science Policy, NIH,
at (301) 496–9838 or SciencePolicy@
od.nih.gov.
SUPPLEMENTARY INFORMATION:
SUMMARY:
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and
Other Communication Disorders;
Notice of Closed Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute on
Deafness and Other Communication
Disorders Special Emphasis Panel; U01
Cooperative Agreement for Clinical Trials in
Hearing Disorders.
Date: November 12, 2024.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate
cooperative agreement applications.
Address: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852.
Meeting Format: Virtual Meeting.
Contact Person: Sonia Elena Nanescu,
Ph.D., Scientific Review Officer, Division of
Extramural Activities, NIDCD, NIH, 6001
Executive Blvd., Suite 8300, Bethesda, MD
20892, (301) 496–8683, sonia.nanescu@
nih.gov.
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
Background
Scientific integrity aims to make sure
that science is conducted, managed,
communicated, and used in ways that
preserve its accuracy and objectivity
and protect it from suppression,
manipulation, and inappropriate
influence (https://www.whitehouse.gov/
wp-content/uploads/2022/01/01-22Protecting_the_Integrity_of_
Government_Science.pdf). In support of
our mission, NIH has always sought to
incorporate robust scientific integrity
principles and practices throughout
every level of its scientific enterprise. In
fostering scientific integrity, NIH aims
to ensure that (1) scientific findings are
objective, credible, and readily available
to the public, and (2) the development
and implementation of policies and
programs is transparent, accountable,
and evidence-based. NIH has numerous
policies and procedures to ensure the
Nation’s investment in biomedical
E:\FR\FM\21OCN1.SGM
21OCN1
]]>Agencies
[Federal Register Volume 89, Number 203 (Monday, October 21, 2024)]
[Notices]
[Page 84166]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-24199]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Deafness and Other Communication Disorders;
Notice of Closed Meeting
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute on Deafness and Other
Communication Disorders Special Emphasis Panel; U01 Cooperative
Agreement for Clinical Trials in Hearing Disorders.
Date: November 12, 2024.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate cooperative agreement
applications.
Address: National Institutes of Health, Neuroscience Center,
6001 Executive Boulevard, Rockville, MD 20852.
Meeting Format: Virtual Meeting.
Contact Person: Sonia Elena Nanescu, Ph.D., Scientific Review
Officer, Division of Extramural Activities, NIDCD, NIH, 6001
Executive Blvd., Suite 8300, Bethesda, MD 20892, (301) 496-8683,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.173,
Biological Research Related to Deafness and Communicative Disorders,
National Institutes of Health, HHS)
Dated: October 15, 2024.
Victoria E. Townsend,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-24199 Filed 10-18-24; 8:45 am]
BILLING CODE 4140-01-P
